JACC: Case Reports (Mar 2021)

Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient

  • Giuseppe Vergaro, MD, PhD,
  • Vincenzo Castiglione, MD,
  • Roberta Poletti, MD,
  • Gabriele Buda, MD,
  • Angela Pucci, MD, PhD,
  • Veronica Musetti, BSc,
  • Dario Genovesi, MD,
  • Alberto Aimo, MD,
  • Claudio Passino, MD,
  • Michele Emdin, MD, PhD

Journal volume & issue
Vol. 3, no. 3
pp. 450 – 454

Abstract

Read online

Currently adopted diagnostic flow charts consider transthyretin and light-chain cardiac amyloidosis as mutually exclusive. Here, we report for the first time, to our knowledge, the demonstration of a biopsy-proven dual pathology in an 80-year-old man with sequential development of both wild-type transthyretin amyloidosis and light-chain cardiac amyloidosis cardiomyopathy over a 3-year timespan. (Level of Difficulty: Intermediate.)

Keywords